Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release May 04 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 04, 2023, titled "Zydus receives final approval from the USFDA for Sucralfate Tablets USP, 1 gram".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases